Vaccinex

(OTC) VCNX

Current Price$1.01

Market Cap$2.68M

Since IPO (2018)-100%

5 Year-100%

1 Year+2%

1 Month+10%

Vaccinex Financials at a Glance

Market Cap

$2.68M

Revenue (TTM)

$601.00K

Net Income (TTM)

$18.63M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

1.39 (Average)

Dividend

$0.00

Beta (Volatility)

1.39 (Average)

Price

$1.01

Volume

1,769

Open

$1.00

Price

$1.01

Volume

1,769

Open

$1.00

Previous Close

$1.00

Daily Range

$1.00 - $1.50

52-Week Range

$0.31 - $1.50

Dividend

$0.00

Beta (Volatility)

1.39 (Average)

Price

$1.01

Volume

1,769

Open

$1.00

Previous Close

$1.00

Daily Range

$1.00 - $1.50

52-Week Range

$0.31 - $1.50

VCNX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vaccinex

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Maurice Zauderer, PhD

Website

www.vaccinex.com

Headquarters

Rochester, NY 14620, US

VCNX Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-31%

Net Income Margin

-31%

Return on Equity

Return on Capital

Return on Assets

-7%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.68M

Shares Outstanding

2.68M

Volume

1.77K

Avg. Volume

2.82K

Financials (TTM)

Gross Profit

$601.00K

Operating Income

$18.73M

EBITDA

$18.54M

Operating Cash Flow

$16.19M

Capital Expenditure

$22.00K

Free Cash Flow

$16.21M

Cash & ST Invst.

$1.11M

Total Debt

$25.00K

Vaccinex Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2024YOY CHG

Revenue

$213.00K

+155.2%

Gross Profit

$213.00K

+903.8%

Gross Margin

100.00%

N/A

Market Cap

$2.68M

N/A

Market Cap/Employee

$116.37K

N/A

Employees

N/A

Net Income

$3.37M

-1.7%

EBITDA

$3.35M

-15.5%

Quarterly Fundamentals

Name

Q4 2024YOY CHG

Net Cash

$1.08M

-16.0%

Accounts Receivable

$838.00K

-12.8%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$25.00K

-88.7%

Return on Assets

-7.18%

N/A

Return on Invested Capital

7.53%

N/A

Free Cash Flow

$3.93M

-9.5%

Operating Cash Flow

$3.93M

-9.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ENZCEnzolytics Inc.

ENZCEnzolytics Inc.$0.00+0.00%

NBCONeon Bloom, Inc.

NBCONeon Bloom, Inc.$0.01-4.35%

CNNACann American Corp.

CNNACann American Corp.$0.00+0.00%

EVFMEvofem Biosciences, Inc.

EVFMEvofem Biosciences, Inc.$0.01+4.48%

GRTXGalera Therapeutics, Inc.

GRTXGalera Therapeutics, Inc.$0.10+13.35%

BMNDFBiomind Labs Inc.

BMNDFBiomind Labs Inc.$0.12+0.00%

MDGEFMedigene AG

MDGEFMedigene AG$2.59+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.10-0.02%

INTCIntel

INTCIntel$96.48-0.03%

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$8.02+2.47%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+1.07%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.75+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.83+0.01%

NCLHNorwegian Cruise Line

NCLHNorwegian Cruise Line$17.12-0.09%

Questions About VCNX

What is the current price of Vaccinex?

Vaccinex is trading at $1.01 per share.

What is the 52-week range for Vaccinex?

Over the past 52 weeks, Vaccinex has traded between $0.31 and $1.50.

How much debt does Vaccinex have?

As of the most recent reporting period, Vaccinex reported total debt of $25,000.

How much cash does Vaccinex have on hand?

Vaccinex reported $1.11M in cash and cash equivalents in its most recent financial results.

What is Vaccinex’s dividend yield?

Vaccinex does not currently have a dividend yield.

Vaccinex

Vaccinex Financials at a Glance

VCNX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Vaccinex

VCNX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Vaccinex Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About VCNX

What is the current price of Vaccinex?

What is the 52-week range for Vaccinex?

How much debt does Vaccinex have?

How much cash does Vaccinex have on hand?

What is Vaccinex’s dividend yield?

Premium Investing Services